287 related articles for article (PubMed ID: 34783212)
1. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis.
Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B;
J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212
[TBL] [Abstract][Full Text] [Related]
2. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
[TBL] [Abstract][Full Text] [Related]
3. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
[TBL] [Abstract][Full Text] [Related]
6. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
[TBL] [Abstract][Full Text] [Related]
7. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
[TBL] [Abstract][Full Text] [Related]
8. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
[TBL] [Abstract][Full Text] [Related]
9. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
[TBL] [Abstract][Full Text] [Related]
10. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
11. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
12. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
13. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
[TBL] [Abstract][Full Text] [Related]
14. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
[No Abstract] [Full Text] [Related]
16. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.
Adam H; Alqassas M; Saadah OI; Mosli M
J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.
Siemanowski B; Regueiro M
Curr Treat Options Gastroenterol; 2007 Jun; 10(3):178-84. PubMed ID: 17547856
[TBL] [Abstract][Full Text] [Related]
20. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
